These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37720349)

  • 21. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research Progress of Conjugated Nanomedicine for Cancer Treatment.
    Zhao B; Chen S; Hong Y; Jia L; Zhou Y; He X; Wang Y; Tian Z; Yang Z; Gao D
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?
    Paldino E; Tesori V; Casalbore P; Gasbarrini A; Puglisi MA
    Biomed Res Int; 2014; 2014():859871. PubMed ID: 24527460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of nanotechnology and gene delivery systems in TRAIL-based therapies.
    Naoum GE; Tawadros F; Farooqi AA; Qureshi MZ; Tabassum S; Buchsbaum DJ; Arafat W
    Ecancermedicalscience; 2016; 10():660. PubMed ID: 27594905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells.
    Wu C; Zhang F; Li B; Li Z; Xie X; Huang Y; Yao Z; Chen Y; Ping Y; Pan W
    Small; 2023 Oct; 19(41):e2301600. PubMed ID: 37328445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
    Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
    J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
    Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
    Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.
    Jain H; Dhawan P; Rao S; Lalwani N; Shand H
    Anticancer Agents Med Chem; 2023; 23(4):368-382. PubMed ID: 36056850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma.
    Dos Santos RP; Roesler R; Gregianin L; Brunetto AT; da Cunha Jaeger M; Lunardi Brunetto A; de Farias CB
    Curr Stem Cell Res Ther; 2023; 18(7):926-936. PubMed ID: 35761483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells.
    Zhang HL; Wang P; Lu MZ; Zhang SD; Zheng L
    Oncol Lett; 2019 May; 17(5):4487-4493. PubMed ID: 30944638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches.
    Sun W; Chen G; Du F; Li X
    Curr Stem Cell Res Ther; 2021; 16(4):367-384. PubMed ID: 33023455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA Repair and Therapeutic Strategies in Cancer Stem Cells.
    Gillespie MS; Ward CM; Davies CC
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.